Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C51H98O6 |
| Molecular Weight | 807.3202 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC
InChI
InChIKey=PVNIQBQSYATKKL-UHFFFAOYSA-N
InChI=1S/C51H98O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-49(52)55-46-48(57-51(54)45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)47-56-50(53)44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h48H,4-47H2,1-3H3
| Molecular Formula | C51H98O6 |
| Molecular Weight | 807.3202 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Nondestructive rheological measurement of aqueous dispersions of solid lipid nanoparticles: effects of lipid types and concentrations on dispersion consistency. | 2010-09 |
|
| A rapid separation technique for overcoming suppression of triacylglycerols by phosphatidylcholine using MALDI-TOF MS. | 2010-08 |
|
| Optimisation of tripalmitin-rich fractionation from palm stearin by response surface methodology. | 2010-07 |
|
| Evolving neural network optimization of cholesteryl ester separation by reversed-phase HPLC. | 2010-07 |
|
| Regulation of hepatic gene expression by saturated fatty acids. | 2010-03-16 |
|
| Two-step solid lipid extrusion as a process to modify dissolution behavior. | 2010-03 |
|
| Investigating the relationship between drug distribution in solid lipid matrices and dissolution behaviour using Raman spectroscopy and mapping. | 2010-03 |
|
| Screening of food grade lipases to be used in esterification and interesterification reactions of industrial interest. | 2010-02 |
|
| Cellular stress responses: cell survival and cell death. | 2010 |
|
| Fatty acid selectivity of lipases during acidolysis reaction between oleic acid and monoacid triacylglycerols. | 2009-11-11 |
|
| Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase. | 2009-09-29 |
|
| Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles. | 2009-09-09 |
|
| Thermostable lipases from the extreme thermophilic anaerobic bacteria Thermoanaerobacter thermohydrosulfuricus SOL1 and Caldanaerobacter subterraneus subsp. tengcongensis. | 2009-09 |
|
| Lipase-catalyzed reactions at interfaces of two-phase systems and microemulsions. | 2009-09 |
|
| Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures. | 2009-08-04 |
|
| Proteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion. | 2009-07-16 |
|
| Influence of structural variations on drug release from lipid/polyethylene glycol matrices. | 2009-07-12 |
|
| Solid lipid nanoparticles: a modern formulation approach in drug delivery system. | 2009-07 |
|
| Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). | 2009-06-01 |
|
| Effect of electromagnetic field and surface modification on the electrical behavior of novel solid lipid nanoparticles covered with l-arginine. | 2009-06-01 |
|
| Biochemical characterization of a putative wheat caffeic acid O-methyltransferase. | 2009-04 |
|
| Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials. | 2009-02 |
|
| Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution. | 2009-01 |
|
| Nanomedicine in pulmonary delivery. | 2009 |
|
| Biosynthesis of storage compounds by Rhodococcus jostii RHA1 and global identification of genes involved in their metabolism. | 2008-12-12 |
|
| Plant products for pharmacology: application of enzymes in their transformations. | 2008-12 |
|
| Polaron hopping in some biomolecular solids and their charge transfer complexes. | 2008-12 |
|
| Temperature scanning ultrasonic velocity study of complex thermal transformations in solid lipid nanoparticles. | 2008-11-18 |
|
| Modeling of the triglyceride-rich core in lipoprotein particles. | 2008-11-06 |
|
| Construction of a taste-blind medaka fish and quantitative assay of its preference-aversion behavior. | 2008-11 |
|
| Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon. | 2008-09 |
|
| Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla. | 2008-09 |
|
| Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. | 2008-09 |
|
| Lipid droplets: a classic organelle with new outfits. | 2008-08 |
|
| Structure-activity relationships of wheat flavone O-methyltransferase: a homodimer of convenience. | 2008-05 |
|
| Micro-scale flow cytometry-based and biochemical analysis of lipid signaling in primary B cell subpopulations. | 2007-12-24 |
|
| Ultrasonic scattering in chocolate and model systems containing sucrose, tripalmitin and olive oil. | 2007-11 |
|
| Slow recrystallization of tripalmitoylglycerol from MCT oil observed by 2H NMR. | 2007-10-17 |
|
| Mechanisms involved in the cytotoxic and cytoprotective actions of saturated versus monounsaturated long-chain fatty acids in pancreatic beta-cells. | 2007-08 |
|
| Effects of stereospecific positioning of fatty acids in triacylglycerol structures in native and randomized fats: a review of their nutritional implications. | 2007-07-12 |
|
| Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. | 2007-07-10 |
|
| Enzymatic production of infant milk fat analogs containing palmitic acid: optimization of reactions by response surface methodology. | 2007-05 |
|
| Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. | 2007-04-20 |
|
| Enzymatic interesterification of tripalmitin with vegetable oil blends for formulation of caprine milk infant formula analogs. | 2007-02 |
|
| High-temperature micro liquid chromatography for lipid molecular species analysis with evaporative light scattering detection. | 2007-01-26 |
|
| Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. | 2007 |
|
| [Effect of crystallization temperature of palm oil on its crystallization. IV. The influence of tripalmitoylglycerol (PPP) on the crystallization of 1,3-dipalmitoyl-2-oleoyl-glycerol (POP) and 1,2-dioleoyl-3-palmitoyl-glycerol (POO)]. | 2007 |
|
| Tripalmitin-based cationic lipospheres: preparation, characterization and in Lab-on-a-chip applications. | 2006-11-28 |
|
| Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. | 2006-11 |
|
| Human milk fat substitutes containing omega-3 fatty acids. | 2006-05-17 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7417398
Mice: tripalmitin (0--250 g fat/kg)
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:56:51 GMT 2025
by
admin
on
Mon Mar 31 17:56:51 GMT 2025
|
| Record UNII |
D133ZRF50U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
TRIPALMITIN
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
m11178
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | Merck Index | ||
|
11147
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
C005859
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
CHEMBL2002154
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
100000076948
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
D133ZRF50U
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
DTXSID8046169
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
209-098-1
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
D133ZRF50U
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
6950
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
77393
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
C78766
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
555-44-2
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
SUB11319MIG
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | |||
|
1368169
Created by
admin on Mon Mar 31 17:56:51 GMT 2025 , Edited by admin on Mon Mar 31 17:56:51 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |